Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Key Points:<ul>
<li>Consumer Discretionary retailers and restaurants continue to demonstrate leadership characteristics. Many are breaking to new price and RS highs.</li>
<li>A number of small-cap E&amp;P’s have developed bullish bases and continue to have constructive RS trends.</li>
<li>A few semi supplier stocks are breaking price and RS downtrends.</li>
</ul>

Key Points:
Consumer Discretionary retailers and restaurants continue to demonstrate leadership characteristics. Many are breaking to new price and RS highs.
A number of small-cap E&amp;P’s have developed bullish bases and continue to have constructive RS trends.
A few semi supplier stocks are breaking price and RS downtrends.


Key points:<ul>
<li>Energy names are showing signs of bottoming with the recent uptick in crude, and weakness in the U.S. dollar</li>
<li>REITs are continuing to firm up as rates have plateaued</li>
<li>Biotech stocks are continuing to show leadership characteristics</li>
</ul>Charts highlighted: AFI, ODP, SPWH, CVS, KMB, THS, CHK, KMI, RRC, AXS, ESS, KIM, APTS, KRG, REGN, NERV, NSTG, RARX, AYI, CFX, AXL, PAH, FNSR, TRUE, ALK, HA, SAVE, and PEGI

Key points:
Energy names are showing signs of bottoming with the recent uptick in crude, and weakness in the U.S. dollar
REITs are continuing to firm up as rates have plateaued
Biotech stocks are continuing to show leadership characteristics
Charts highlighted: AFI, ODP, SPWH, CVS, KMB, THS, CHK, KMI, RRC, AXS, ESS, KIM, APTS, KRG, REGN, NERV, NSTG, RARX, AYI, CFX, AXL, PAH, FNSR, TRUE, ALK, HA, SAVE, and PEGI

Technically Attractive U.S. Stocks for Value Investors

Chart based progressive global trading strategies, Chart Partners

Thomas Schroeder

Chart based progressive global trading strategies

Chart Partners

Chart Partners objective is to discover medium-term cycle turns and profit opportunities before they unfold, within structural trends while preserving capital with clear degrees of risk. We have real return ideas. 

Markets are dynamic and trading systems must reflect this. It is crucial to determine underlying correlations and lead-lag relationships within global markets and the impact on linked instruments. Our weekly Chartonics product gives you short-term trading strategies that can be applied within the medium and longer term macro trends that are mapped out in our strategy updates. 

Our methodology fuses global market variables and isolates drivers in trends. We specialize in FX, index trade in NY and Asia with a focus on Asian stocks. 

This is a follow up insight on the S&amp;P call to buy June/July weakness for a test and push above 2,800 targeting 2,960. A bit of color is required given weaker breadth and sector participation cracks as we enter the more volatile late August/September period. The recent re test and reversal higher off of 2,800 was a confirmation signal the rally will extend. We now face a fade cycle from the 2,860-70 area under the key 2,880 high. Our cycle work implies a harder correction is brewing from…

This is a follow up insight on the S&amp;P call to buy June/July weakness for a test and push above 2,800 targeting 2,960. A bit of color is required given weaker breadth and sector participation cracks as we enter the more volatile late August/September period. The recent re test and reversal higher off of 2,800 was a confirmation signal the rally will extend. We now face a fade cycle from the 2,860-70 area under the key 2,880 high. Our cycle work implies a harder correction is brewing from…

Path to S&P 2,960 Part II - Leadership Fading into September Weakness

Key Points:<ul>
<li>The Staples Sector is leadership and many names are staging price and RS reversals.</li>
<li>REIT’s are breaking above bases and are showing RS leadership.</li>
<li>Paper &amp; Forest products are strengthening and many are reversing price and RS downtrend or breaking above bases.</li>
<li>Large-Cap Pharma stocks are showing leadership. Many have broken topside of multi-year consolidations or have reversed multi-year price and RS downtrends.</li>
</ul><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/059/921/original/Untitled.png?1533586859" class="editor-image img-responsive" data-smartkarma-image-id="59921"></figure>

Key Points:
The Staples Sector is leadership and many names are staging price and RS reversals.
REIT’s are breaking above bases and are showing RS leadership.
Paper &amp; Forest products are strengthening and many are reversing price and RS downtrend or breaking above bases.
Large-Cap Pharma stocks are showing leadership. Many have broken topside of multi-year consolidations or have reversed multi-year price and RS downtrends.


Nasdaq-100 Stock Index / Technical Analysis

The tech and biotech-heavy Nasdaq continues to lead the market higher. Remain overweight. On the back of rising interest rates and a recently steepening yield curve, the XLF is on the cusp of a breakout from a descending triangle/falling wedge pattern. Given this move has been accompanied by improving relative strength, we view it as a bullish sign for both Financials and the broad market.  In today’s report we highlight attractive Groups and stocks within the Consumer Discretionary, Transportation, and Manufacturing sectos.

 The tech and biotech-heavy Nasdaq continues to lead the market higher. Remain overweight. On the back of rising interest rates and a recently steepening yield curve, the XLF is on the cusp of a breakout from a descending triangle/falling wedge pattern. Given this move has been accompanied by improving relative strength, we view it as a bullish sign for both Financials and the broad market.  In today’s report we highlight attractive Groups and stocks within the Consumer Discretionary, Transportation, and Manufacturing sectos.

Remain Overweight Tech; Large-Cap Financials on the Cusp of a Breakout

United States

The NASDAQ-100 Index is a modified capitalization-weighted index of the 100 largest and most active non-financial domestic and international issues listed on the NASDAQ. No security can have more than a 24% weighting. The index was developed with a base value of 125 as of February 1, 1985. Prior to December 21,1998 the Nasdaq 100 was a cap-weighted index.

Nasdaq-100 Stock Index (NDX INDEX)

Vital Signs: Actionable U.S. Stocks

Key Points: Consumer Discretionary retailers and restaurants continue to demonstrate leadership characteristics. Many are breaking to new price and...

Vermilion Research

Technically Attractive U.S. Stocks for Value Investors

Key points: Energy names are showing signs of bottoming with the recent uptick in crude, and weakness in the U.S. dollar REITs are continuing to...

Vermilion Research

Path to S&P 2,960 Part II - Leadership Fading into September Weakness

This is a follow up insight on the S&P call to buy June/July weakness for a test and push above 2,800 targeting 2,960. A bit of color is...

Thomas Schroeder

U.S. Vital Signs: Actionable Stocks

Key Points: The Staples Sector is leadership and many names are staging price and RS reversals. REIT’s are breaking above bases and are showing RS...

Vermilion Research

Remain Overweight Tech; Large-Cap Financials on the Cusp of a Breakout

The tech and biotech-heavy Nasdaq continues to lead the market higher. Remain overweight. On the back of rising interest rates and a recently...

Vermilion Research